ten [ten196196196196196196196196196196196196196196196196196196196196196196196196196196196196196196196196196196196 19659004] It delivers a surge of radiotherapy directly to the prostate in a single session
A single blast of radiotherapy could save prostate cancer patients weeks of grueling treatments, research suggests.
High dose-rate brachytherapy – which delivers a powerful The findings, presented at the European Society for Radiotherapy and Oncology Conference in Milan, suggest patients can be
The researchers, from the Christie hospital at Manchester and Mount Vernon in London, found that they were three years after receiving low-risk cancer the treatment, which usually takes just to 20 minutes.
Prostate cancer – but in a state of failure higher dose may be needed for aggressive cancer types.
The Daily Mail is campaigning for urgent improvement to prostate cancer treatments and diagnosis.
But the single-blast high dose-rate or 'HDR' brachytherapy is available in only a few of the NHS hospitals.
The vast majority of those receiving external beam radiotherapy, which bathes the entire pelvis in a low-powered radioactive beam.
Brachytherapy instead of fires a higher dose of radiation via thin tubes directly into the prostate gland for a few minutes to destroy the cancer cells.
Some 15,000 men with prostate cancer receive radiotherapy every year – nearly a third of the 47,000 men diagnosed in Britain annually. NHS hospitals across the country [File photo]” class=”blkBorder img-share” />
Some 15,000 men with prostate cancer receive radiotherapy every year – nearly a third of the 47,000 men diagnosed in Britain annually. NHS hospitals across the country [File photo]
Brachytherapy has been used in Britain for a few years, but has usually been delivered in several sessions of lower-powered Doses to visit hospital between four and nine times.
Researchers Dr Hannah Tharmalingam said: 'These results indicate that high dose-rate brachytherapy is a safe and effective treatment for low-risk prostate cancer.
'It is therefore a patient-friendly option because the treatment can be given quickly at a single hospital visit.'
Dr Bradley Pieters, chair of the European Radiotherapy and Oncology Brachytherapy Committee, said: 'This research suggests a single treatment of high-dose rate brachytherapy y could be a good option for many with prostate cancer.
'The technology and expertise needed to deliver this treatment is not yet available in all cancer centers. However, that it may offer time and money savings for hospitals as well as benefits to patients. "